These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22334925)

  • 1. [The results of adjuvant therapy of juvenile recurring respiratory papillomatosis with the use of indole-3-carbinol].
    Soldatskiĭ IuL; Onufrieva EK; Steklov AM; Gasparian SF; Strygina IuV
    Vestn Otorinolaringol; 2011; (5):47-50. PubMed ID: 22334925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children.
    Rogers DJ; Ojha S; Maurer R; Hartnick CJ
    JAMA Otolaryngol Head Neck Surg; 2013 May; 139(5):496-501. PubMed ID: 23681032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results.
    Rosen CA; Bryson PC
    J Voice; 2004 Jun; 18(2):248-53. PubMed ID: 15193659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of juvenile onset recurrent respiratory papillomatosis in the lower respiratory tract.
    Wang J; Han DM; Ma LJ; Ye JY; Xiao Y; Yang QW
    Chin Med J (Engl); 2012 Oct; 125(19):3496-9. PubMed ID: 23044312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is recurrent respiratory papillomatosis a manageable or curable disease?
    Kim HT; Baizhumanova AS
    Laryngoscope; 2016 Jun; 126(6):1359-64. PubMed ID: 26608928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosis.
    Kimberlin DW
    Antiviral Res; 2004 Sep; 63(3):141-51. PubMed ID: 15451182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative Systemic Acyclovir in Juvenile-Onset Recurrent Respiratory Papillomatosis: The Outcome.
    Mitra S; Das A; Ghosh D; Sengupta A
    Ear Nose Throat J; 2019 Jan; 98(1):28-31. PubMed ID: 30834790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of juvenile onset recurrent respiratory papillomatosis caused by human papillomavirus.
    Hawkes M; Campisi P; Zafar R; Punthakee X; Dupuis A; Forte V; Ford-Jones EL
    Pediatr Infect Dis J; 2008 Feb; 27(2):149-54. PubMed ID: 18174855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary report of endolaryngeal and endotracheal laser surgery of juvenile-onset recurrent respiratory papillomatosis by Nd:YAG laser and a new fiber guidance instrument.
    Janda P; Leunig A; Sroka R; Betz CS; Rasp G
    Otolaryngol Head Neck Surg; 2004 Jul; 131(1):44-9. PubMed ID: 15243556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile respiratory papillomatosis: risk factors for severity.
    Rodier C; Lapointe A; Coutlée F; Mayrand MH; Dal Soglio D; Roger M; Trottier H
    J Med Virol; 2013 Aug; 85(8):1447-58. PubMed ID: 23765781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment With Quadrivalent Human Papillomavirus Vaccine for Juvenile-Onset Recurrent Respiratory Papillomatosis: Case Report and Review of the Literature.
    Katsuta T; Miyaji Y; Offit PA; Feemster KA
    J Pediatric Infect Dis Soc; 2017 Nov; 6(4):380-385. PubMed ID: 28992265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis.
    Rosen CA; Woodson GE; Thompson JW; Hengesteg AP; Bradlow HL
    Otolaryngol Head Neck Surg; 1998 Jun; 118(6):810-5. PubMed ID: 9627242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Activity of Nivolumab for Human Papilloma Virus-Related Juvenile-Onset Recurrent Respiratory Papillomatosis.
    Creelan BC; Ahmad MU; Kaszuba FJ; Khalil FK; Welsh AW; Ozdemirli M; Grant NN; Subramaniam DS
    Oncologist; 2019 Jun; 24(6):829-835. PubMed ID: 30842242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of indinol in antirecurrence therapy of juvenile respiratory papillomatosis].
    Soldatskiĭ IuL; Kiselev VI; Onufrieva EK; Steklov AM; Shchepin NV; Strygina IuV; Gasparian SF; Pogosova IE
    Vestn Otorinolaringol; 2006; (1):46-8. PubMed ID: 16482011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and molecular biology studies of respiratory papillomatosis].
    Mahnke CG; Werner JA; Fröhlich O; Lippert BM; Hoffmann M; Rudert HH
    Laryngorhinootologie; 1998 Mar; 77(3):157-64. PubMed ID: 9577823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of long-term leukocyte interferon (alpha IFN) therapy using an individually determined dose schedule in recurrent laryngeal papillomatosis].
    Gerein V; Lodemann E; Bell G; von Ilberg C; Kornhuber B
    Klin Padiatr; 1987; 199(3):224-9. PubMed ID: 3114545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent respiratory papillomatosis presenting to an emergency department.
    Burns SC; Leonard P
    Eur J Emerg Med; 2010 Apr; 17(2):116-8. PubMed ID: 19855282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and molecular biology studies of laryngeal papillomatosis].
    Mahnke CG; Werner JA; Fröhlich O; Lippert BM; Hoffman H; Rudert HH
    Laryngorhinootologie; 1998 Jan; 77(1):27-33. PubMed ID: 9522309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anesthesia management in pediatric patients with laryngeal papillomatosis undergoing suspension laryngoscopic surgery and a review of the literature.
    Bo L; Wang B; Shu SY
    Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1442-5. PubMed ID: 21907420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population.
    Wiatrak BJ; Wiatrak DW; Broker TR; Lewis L
    Laryngoscope; 2004 Nov; 114(11 Pt 2 Suppl 104):1-23. PubMed ID: 15514560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.